Eating Disorders Trial, Recruiting NCT02390765 Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT02390765
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For parents or guardians:

  • You are 18 years old or older.
  • You have a child who is enrolled in this study.

For child participants:

  • The child is between 8 and 17 years old (and may continue in the study as an adult during follow-up).
  • The child's weight, height, and body mass index (a measure using height and weight) are at or above the 5th percentile for their age and sex, based on standard US growth charts.
  • The child is able to understand and complete the study tasks (based on a standard cognitive assessment score of 70 or above).
  • The child is generally in good health, based on a medical history and physical check-up (being overweight or having minor, well-managed health conditions is acceptable).

Who may not be able to join:

For parents or guardians:

  • Your child does not meet the eligibility requirements for the study.
  • The medical team believes you have a health or mental health condition that could make it unsafe for you to complete the study procedures (this is assessed individually).

For child participants:

  • The child has a history of serious heart or cardiovascular disease, or other serious health complications related to being overweight, such as high blood pressure or blood sugar levels high enough to indicate diabetes (fasting blood sugar above 126 mg/dL).
  • The child has a serious ongoing illness affecting the kidneys, liver, digestive system, lungs (other than asthma not requiring daily medication), blood, or certain hormonal conditions (such as Cushing syndrome or untreated thyroid problems).
  • The child regularly takes medication known to affect body weight or eating habits (for example, some ADHD medications) — other medications may be reviewed individually.
  • The child is currently pregnant or has been pregnant before; girls who have started their period will need a negative pregnancy test before joining.
  • The child currently and regularly uses tobacco or alcohol.
  • The child has lost more than 5% of their body weight in the past three months, for any reason.
  • The child has a history of a significant or recent head injury, including any loss of consciousness lasting 30 minutes or more, memory loss or hospitalisation from a head injury, or two or more concussions in the past year.
  • The child has a diagnosed full psychiatric disorder (such as schizophrenia, bipolar disorder, anorexia, bulimia, or substance abuse) that the study team feels would prevent them from safely completing the study — they would be referred for appropriate care instead.
  • Any other condition in the child or parent/guardian that the study team feels would prevent the child from completing the study (for example, a significant learning disorder).

Additional exclusions for the optional stool sample collection part of the study:

  • The child has been diagnosed with or has a history of inflammatory bowel disease (such as ulcerative colitis or Crohn's disease), coeliac disease, irritable bowel syndrome, or other inflammatory gut conditions.
  • The child has had diarrhoea within 1 week before providing the sample.
  • The child has taken antibiotics within 4 weeks before providing the sample.

Additional exclusions for Experiment 1 only:

  • The child regularly takes medications that could affect the nervous system or hormone levels, such as alpha or beta blockers, oral contraceptives, or prescription pain medication.
  • The child scores as "highly active" on a standard physical activity questionnaire, due to the effect high activity levels can have on stress hormone responses (confirm with trial site).

Additional exclusions for Experiment 2 only:

  • The child cannot safely have an MRI or MEG scan — for example, because they have metal in or on their body, braces, certain implants (such as cochlear implants), brain clips, or certain tattoos (including permanent makeup) that may contain metals (confirm with trial site).
  • The child is left-handed.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bobby K Cheon, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phone: (301) 827-1857

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Registry
ClinicalTrials.gov
Start date
21 April 2015
Est. completion
12 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Differences in eating behavior of pediatric participants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov